Business Context and Reporting Period
This Form 8-K Current Report is filed by Future Vision II Acquisition Corp., a Cayman Islands-based emerging growth company, for the reporting period of May 6, 2026. The Company's securities (Units, Ordinary Shares, and Rights) trade on The Nasdaq Capital Market under the symbols FVNNU, FVN, and FVNNR, respectively.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on regulatory compliance status rather than financial performance.
Material Changes
On May 5, 2026, the Company received a written notice from Nasdaq indicating non-compliance with the minimum number of public holders required for continued listing (Listing Rule 5550(a)(3)). This notice is a notification of deficiency and does not currently affect the listing or trading of the Company's securities.
Outlook, Risks, and Management Commentary
- Compliance Timeline: The Company has 45 calendar days from the notice date (until June 22, 2026) to submit a plan to regain compliance.
- Extension Possibility: If a compliance plan is accepted, Nasdaq may grant an extension of up to 180 calendar days to evidence compliance.
- Appeal Rights: If the plan is not accepted, the Company may appeal the decision to a Nasdaq Hearings Panel.
- Management Action: The Company is actively evaluating options to resolve the deficiency and intends to submit a plan within the required timeframe.
- Risk Warning: There is no assurance that the Company will be able to regain compliance with Nasdaq listing requirements or maintain compliance with other standards.
Investor Verification Checklist
- Verify the current number of public holders to assess the severity of the deficiency.
- Monitor the submission of the compliance plan by the June 22, 2026 deadline.
- Track Nasdaq's decision on the acceptance of the compliance plan and any potential extension granted.
- Review subsequent filings for updates on the Company's efforts to regain listing compliance.